To investigate the inhibitory effect of HMGN2 knockdown on GBM proliferation in vivo, the HMGN2 knockdown and control groups were injected with NOD/SCID mice to generate intracranial xenograft models. The gene discussed is HMGN2; the disease is glioblastoma.